Growth Metrics

OptimizeRx (OPRX) Receivables - Net (2016 - 2026)

OptimizeRx's Receivables - Net history spans 16 years, with the latest figure at $37.8 million for Q4 2025.

  • On a quarterly basis, Receivables - Net fell 1.2% to $37.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $37.8 million, a 1.2% decrease, with the full-year FY2025 number at $37.8 million, down 1.2% from a year prior.
  • Receivables - Net hit $37.8 million in Q4 2025 for OptimizeRx, up from $32.2 million in the prior quarter.
  • Over the last five years, Receivables - Net for OPRX hit a ceiling of $38.2 million in Q4 2024 and a floor of $757218.0 in Q3 2021.
  • Historically, Receivables - Net has averaged $21.2 million across 5 years, with a median of $23.3 million in 2022.
  • Biggest five-year swings in Receivables - Net: tumbled 94.32% in 2021 and later surged 724.22% in 2024.
  • Tracing OPRX's Receivables - Net over 5 years: stood at $24.8 million in 2021, then dropped by 10.67% to $22.2 million in 2022, then skyrocketed by 63.63% to $36.3 million in 2023, then grew by 5.4% to $38.2 million in 2024, then dropped by 1.2% to $37.8 million in 2025.
  • Business Quant data shows Receivables - Net for OPRX at $37.8 million in Q4 2025, $32.2 million in Q3 2025, and $33.5 million in Q2 2025.